Anglo-Scandinavian Cardiac Outcomes Trial - ASCOT - Main protocol summary and sub-study protocols - Editor's note

被引：0
|
作者：
O'Brien, E
机构：
来源：
JOURNAL OF HUMAN HYPERTENSION | 2001年 / 15卷
关键词：
D O I：
10.1038/sj.jhh.1001240
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [31] Platelet indexes in relation to target organ damage in high-risk hypertensive patients - A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Nadar, SK
    Blann, AD
    Kamath, S
    Beevers, DG
    Lip, GYH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) : 415 - 422
  • [32] The Anglo-Scandinavian Cardiac Outcomes Trial:: Blood pressure-lowering limb (ASCOT-BPLA):: effects in patients with type 2 diabetes
    Ostergren, J.
    Sever, P.
    Poulter, N.
    Dahlof, B.
    Wedel, H.
    Beevers, G.
    Caulfield, M.
    Collins, R.
    Kjeldsen, S.
    Kristinsson, A.
    McInnes, G.
    Mehlsen, J.
    Nieminen, M.
    OBrien, E.
    DIABETOLOGIA, 2006, 49 : 136 - 137
  • [33] Prevention of coronary and stroke events with atorvastatin in hypertensive patients - ASCOT-LLA (the Anglo-Scandinavian cardiac outcomes trial - Lipid lowering arm)
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (05) : 75 - 75
  • [34] The effect on blood pressure and lipid profiles of doxazosin gits as a third-line antihypertensive agent in the anglo-Scandinavian cardiac outcomes trial (ASCOT)
    Chang, C. L.
    Chapman, J. N.
    Sever, P. S.
    Dahlöf, B.
    Wedel, H.
    Poulter, N. R.
    JOURNAL OF HYPERTENSION, 2006, 24 : S3 - S4
  • [35] Health economics of prevention of coronary heart disease and vascular events:: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Jönsson, B
    Buxton, M
    Hertzman, P
    Kahan, T
    Poulter, N
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (Suppl 1) : S53 - S56
  • [36] Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?
    Sever, PS
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 3S - 9S
  • [37] Differential Effects of Antihypertensive Treatment on the Retinal Microcirculation An Anglo-Scandinavian Cardiac Outcomes Trial Substudy
    Thom, Simon
    Stettler, Christoph
    Stanton, Alice
    Witt, Nicholas
    Tapp, Robyn
    Chaturvedi, Nish
    Allemann, Sabin
    Mayet, Jamil
    Sever, Peter
    Poulter, Neil
    O'Brien, Eoin
    Hughes, Alun
    HYPERTENSION, 2009, 54 (02) : 405 - 408
  • [38] Amlodipine plus atorvastatin is cost-effective compared to atenolol plus atorvastatin, amlodipine or atenolol alone: The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Lindgren, P.
    Buxton, M.
    Kahan, T.
    Poulter, N.
    Dahlof, B.
    Sever, P. S.
    Wedel, H.
    Jonsson, B.
    EUROPEAN HEART JOURNAL, 2007, 28 : 857 - 857
  • [39] Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    B Jönsson
    M Buxton
    P Hertzman
    T Kahan
    N Poulter
    Journal of Human Hypertension, 2001, 15 : S53 - S56
  • [40] Do statins lower blood pressure? Evidence from the anglo-scandinavian cardiac outcomes trial-lipid-lowering arm (ASCOT-LLA)
    Poulter, N
    Sever, PS
    CIRCULATION, 2004, 110 (17) : 402 - 402
12345